IPAD
OtherParticipant will play a game through (standard camera) participants will be able to the hospital room and decals as they appear in the real world
NCT Number: NCT05466994
To learn if playing an augmented reality game called SpellBound can reduce pain and the need for opioids in young patients scheduled for surgery.
Looking for future studies?
Notify Me5 year–15 year
All sexes
Interventional
Phase 2
M D Anderson Cancer Center, Houston, Texas, United States
Primary Objective:
•To assess the efficacy of SpellBound's AR-enabled scavenger hunt to reduce the rate of 90-day opioid use in pediatric cancer patients undergoing surgery compared to a control non-AR game in a randomized controlled trial.
Secondary Objectives:
To assess the effect of AR versus non-AR control technology in pediatric oncology patients, including:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participant will play a game through (standard camera) participants will be able to the hospital room and decals as they appear in the real world
Participants will play a game through (devices camera and application) let us participants view the real world
Time frame: through completion of study, an average of 1 year
Quality of life assessment-Age-appropriate Pediatric Quality of Life Inventory (PedsQL)29 paper surveys will be administered to the patient (self-report) or guardian (proxy) when patients reach discharge-ready status. Score scales (0-4) 0-Never/4 Almost Always
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03455140
Cancer, Hematologic Diseases
Adelaide, Australia
View Trial DetailsNCT07041216
Hematologic Diseases, Hemic and Lymphatic Diseases
Antalya, Turkey (Türkiye)
View Trial DetailsNCT03964259
Acute Lymphoblastic Leukemia, Hematologic Diseases
Richmond, Virginia, United States
View Trial DetailsNCT05528939
Attention Difficulties, Cognitive Deficit in Attention
Washington D.C., District of Columbia, United States
View Trial Details